Images in this collection

February 1, 2021, Asuncion, Paraguay: Illustration photo of logo of Novavax, Inc. (Nasdaq: NVAX), a biotechnology company, seen displayed on smartphone behind a syringe with needle in front of waving flag of the United States, the words coronavirus disease (COVID-19) and visual representation of virus. Novavax announced on Jan 28 that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical trial conducted in the United Kingdom Asuncion Paraguay - ZUMAc217 20210201_zip_c217_001 Copyright: xAndrexM.xChangx